[Broncho-Vaxom in the treatment of chronic pulmonary lesions].
Two hundred patients with various chronic pulmonary diseases were treated with the bacterial lysate Broncho-Vaxom (BV) in addition to conventional treatment, or alone, over a period of 2 years. The efficacy of BV was assessed ob the basis of clinical symptoms (dyspnoea, cough, expectoration, fever and bronchial rales), pulmonary function, number of relapses and immune status, in particular serum immunoglobulins A, G and M. The results demonstrated the efficacy of BV in the treatment and prevention of chronic pulmonary disease. In patients treated with BV, clinical symptoms improved significantly compared to controls, incidence of infectious episodes was reduced and impaired immune functions were restored. BV was generally well tolerated.
Basacopol
A
A
Spitalul de pneumoftiziologie, Bucureşti.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D001419:Bacteria; D002457:Cell Extracts; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D000095983:Bacterial Lysates
D000276:Adjuvants, Immunologic; D002457:Cell Extracts; C030259:Broncho-Vaxom; D000095983:Bacterial Lysates
Broncho-Vaxom în tratamentul afecţiunilor pulmonare cronice.